Scientists identified colibactin, a bacterial toxin produced by some variants of E coli in the gut, as a potential driver of early-onset colorectal cancer with hallmark mutations caused by colibactin three times more common in tumours from people under 40 than in those from people over 70.Photograph: Science Photo Library/Alamy

Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among those under 50, MPs have heard.

Cases of early-onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.